Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
about
Cyclophosphamide for connective tissue disease-associated interstitial lung diseaseIncidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UKTumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specificRecent Treatments of Interstitial Lung Disease with Systemic SclerosisLocalisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lungIn search of a cause of cryptogenic fibrosing alveolitis (CFA): one initiating factor or many?Scleroderma lung diseaseCombination therapies for systemic sclerosis.A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.Autoimmune-featured interstitial lung disease: a distinct entity.Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scansClinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis.Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study.The respiratory system in connective tissue disorders.Predictors of mortality in patients with interstitial lung disease treated with corticosteroids: results from a cohort studyChallenges in pulmonary fibrosis x 5: the NSIP/UIP debate.Outcomes of lung transplantation in patients with scleroderma.The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis.Mortality rates from cryptogenic fibrosing alveolitis in seven countries.Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis.Angiotensin II type 1 and 2 receptors and lymphatic vessels modulate lung remodeling and fibrosis in systemic sclerosis and idiopathic pulmonary fibrosisPulmonary complications: one of the most challenging complications of systemic sclerosis.Immunizations in adult patients with systemic sclerosis.Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?The promising role of lung ultrasound in systemic sclerosis.Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung diseaseIncreased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis.Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.Cryptogenic fibrosing alveolitis: have we made any progress?Eosinophil alveolitis in two patients with idiopathic pulmonary fibrosis.A decision model for the watch-and-wait strategy in systemic sclerosis-associated interstitial lung disease.The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis.Low influenza vaccination rate among patients with systemic sclerosis.Cyclophosphamide for connective tissue disease-associated interstitial lung disease.Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia.Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease.Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes.The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.Lower-lobe shrinkage relative to total lung volume in collagen vascular diseases.
P2860
Q24201486-307A3796-6498-436D-8B1E-3FF564AFF1A3Q24670477-8FAAE8EA-A054-4B39-BEEE-2D6E4398707FQ24798801-17C13E67-FFAE-4294-BB7B-695A146356F5Q26773161-7E096E2A-3631-4E69-9C63-07313626F877Q28367151-5E3921C3-6776-4AF0-BC50-A24DE13D78E0Q33588114-D349703D-CA68-4F85-AAC1-A8FE200EDA39Q33919119-BA04A094-D7DE-4A4E-8AA1-F632D2F4C2C7Q34309698-1B8FCD9C-2A3C-4DB5-A66D-652C6C6C7241Q34585630-C80A9F35-E6BA-4F2D-BBC0-453F42318AFCQ35497224-6ECE7C72-E9AE-4A27-9D32-72827A6A66EBQ35563419-BBA6B989-5B49-4F47-8523-0425B2593A52Q35760198-5138C904-F80F-44D4-B035-EC2EE524859DQ36067727-ECFD43C5-3969-4672-A820-EC9EAFE8A04BQ36117547-FD4ACDD0-5853-4342-A930-4C1F774B11E9Q36193846-8DD6692C-BEFF-4796-AEF0-287B8A9729D7Q36225469-A0284A19-8F76-40C3-89D0-EF7A65D4E18CQ36285111-BF156DCA-5DD7-44C3-BD7B-4D4FF1A50308Q36447402-BD17E1A3-44E0-41D7-BC54-A4C0E30CD28DQ36496348-25413162-18A6-4638-8D9A-6E1550871703Q36570301-6111F4C7-FB43-4FD8-8DBC-E1057C748982Q37408603-63E27269-E10C-4E10-B746-F8533C14A2E6Q37504310-1DE124C7-DE65-47E5-B40C-5547EE06EA6FQ37598324-2137D249-6094-4EA4-8E3C-8D9C5F95A834Q37782153-B1D46D0D-5675-40A2-919E-C1FFE004BD03Q37845609-79A9549B-46E5-4C8B-8990-CE538BEAFB8CQ38030450-22AF2C9C-720B-4592-A78A-C98AE1FF6A2DQ38649246-27C47283-3013-4FCF-890D-A63129EA55CCQ39704631-F480AF3C-C186-4974-84BA-47E1A3CF4AF4Q40234409-6FF0C2BE-133B-4043-9EE5-BEE71800C84BQ40917526-E9C79879-217C-4911-B9BF-7401BA488A8BQ41010744-95731478-9F8B-4CD7-8314-0D793B6178CAQ41739942-97EA7401-EC2E-4570-ACC4-9BA9426D86BDQ43872514-B8229B8B-4641-4E2C-90AD-1E389489ECC8Q46887346-F0F690F3-0FBB-4300-A00E-EF27D083227FQ47216089-A2C02697-E3C5-4FE4-A061-ED14E9420ADFQ47751998-84258306-7D88-4656-995D-BD1CCAB0F2AFQ47769077-61C87894-9EE3-473E-B390-D07940D4A5A0Q51770667-07A3C677-3610-411F-B7CF-77DB572FA803Q52927020-D96D6F57-8645-4BA6-93CF-FF7DE7A8CCE9Q53288652-BC8F9378-415E-4552-B562-94C7B4DBEE0B
P2860
Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Fibrosing alveolitis associate ...... ptogenic fibrosing alveolitis.
@en
Fibrosing alveolitis associate ...... ptogenic fibrosing alveolitis.
@nl
type
label
Fibrosing alveolitis associate ...... ptogenic fibrosing alveolitis.
@en
Fibrosing alveolitis associate ...... ptogenic fibrosing alveolitis.
@nl
prefLabel
Fibrosing alveolitis associate ...... ptogenic fibrosing alveolitis.
@en
Fibrosing alveolitis associate ...... ptogenic fibrosing alveolitis.
@nl
P2093
P1476
Fibrosing alveolitis associate ...... ptogenic fibrosing alveolitis.
@en
P2093
Cullinan P
Du Bois RM
Hansell DM
Newman-Taylor AJ
P304
P356
10.1164/AJRCCM.149.6.8004317
P407
P577
1994-06-01T00:00:00Z